J&J loses bid to have $4.7 billion talc verdict set aside, vows to appeal

Thu, 20 Dec 2018 - 09:47 GMT

Johnson & Johnson failed to persuade a Missouri trial judge to set aside a July verdict awarding a record $4.69 billion to 22 women who blamed their ovarian cancer on asbestos in the company’s Baby Powder.

Indian drug inspectors seize Johnson & Johnson Baby Powder samples: source

Wed, 19 Dec 2018 - 09:29 GMT

Johnson & Johnson said on Monday it planned to buy back up to $5 billion of its stock, after $40 billion was wiped from its market value following the Reuters report.

J&J moves to limit impact of Reuters report on asbestos in Baby Powder

Tue, 18 Dec 2018 - 09:41 GMT

“Since tests for asbestos in talc were first developed, J&J’s Baby Powder has never contained asbestos,” Gorsky said in the video here. He added that regulators “have always found our talc to be asbestos-free.”

J&J Baby Powder litigation takes new focus with asbestos claims

Mon, 16 Apr 2018 - 07:46 GMT

J&J says the documents present no such evidence, but merely show the company’s caution.